advertisement
Yu J 19
Showing records 1 to 19 | Display all abstracts from Yu J98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
Niu F
eLife 2022; 11:
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Yan H
International Ophthalmology 2022; 42: 2175-2184
98497 Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma
Li S; Qiu Y
British Journal of Ophthalmology 2023; 107: 828-835
98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
Han P
eLife 2022; 11:
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Tan X
International Ophthalmology 2022; 42: 2175-2184
98497 Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma
Yu J
British Journal of Ophthalmology 2023; 107: 828-835
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Yu J
International Ophthalmology 2022; 42: 2175-2184
98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
Zhang J
eLife 2022; 11:
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Liang T; Liang T
International Ophthalmology 2022; 42: 2175-2184
98497 Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma
Shao M
British Journal of Ophthalmology 2023; 107: 828-835
98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
She Y; Yang L
eLife 2022; 11:
98497 Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma
Li Y
British Journal of Ophthalmology 2023; 107: 828-835
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Shi W; Li L
International Ophthalmology 2022; 42: 2175-2184
98497 Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma
Cao W
British Journal of Ophthalmology 2023; 107: 828-835
98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
Yu J
eLife 2022; 11:
98497 Serum complement component 3, complement component 4 and complement component 1q levels predict progressive visual field loss in older women with primary angle closure glaucoma
Sun X
British Journal of Ophthalmology 2023; 107: 828-835
98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
Zhuang M
eLife 2022; 11:
98582 The occurrence timeline of steroid-induced ocular hypertension and cataract in children with systemic autoimmune diseases
Peng C
International Ophthalmology 2022; 42: 2175-2184
98865 The mA reader YTHDF2 is a negative regulator for dendrite development and maintenance of retinal ganglion cells
Tang K; Shi Y; Yang B; Liu C; Peng B; Ji SJ
eLife 2022; 11:
